PKM and malignant colon neoplasm: Furthermore, NPD10084, as confirmed by the cellular thermal shift assay in colon cancer cells, disrupts PKM2 interactions with β-catenin and STAT3, thereby inhibiting downstream oncogenic signaling and suppressing CRC proliferation (94).